Top Markets
#1 Velas Velas +367.73%
#2 Gravity Gravity +49.99%
#3 Galxe Galxe +35.17%
#4 Derive Derive +31.29%
#5 Infinity Ground Infinity Ground +29.18%
#6 Wiki Cat Wiki Cat +25.33%
#7 Audiera Audiera +24.94%
#8 Fuzzybear Fuzzybear +22.68%
#9 Fetch.ai Fetch.ai +22.26%
#10 Wrapped QUIL Wrapped QUIL +21.56%
Coin of the day
Velas Velas
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
Classifica tra le azioni #20716
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel... MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.
Prezzo delle azioni
$0.00001
Capitalizzazione di mercato
$50.01K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia MultiCell Technologies, Inc. (MCET)

Categoria

Healthcare
Capitalizzazione di mercato
Ricavi
altro
Utili
Storico dei prezzi
Rapporto P/E
Rapporto P/S
Rapporto P/B
Margine operativo
EPS
Frazionamenti azionari
Dividendi
Rendimento da dividendi
Azioni in circolazione
Utile per MultiCell Technologies, Inc. (MCET)
Utile nel Aug 2015 TTM: $-253.70
Secondo gli ultimi rapporti finanziari di MultiCell Technologies, Inc., gli utili attuali della società sono $-253.70. Nel 2013, la società ha registrato un utile di $-1.37K, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di MultiCell Technologies, Inc. dal 2013 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $-253.70 -52.03%
2014 $-528.83 -61.38%
2013 $-1.37K 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
$20.46B -8,063,391,933.22%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$4.64B -1,830,164,385.94%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
$5.23B -2,061,733,458.56%
US
UCB SA UCB SA
UCB SA
UCB.BR
$2.14B -842,594,116.58%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -636,286,470.34%
AU